1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Atopic Dermatitis Market - Growth, Trends, and Forecast (2019 - 2024)

Atopic Dermatitis Market - Growth, Trends, and Forecast (2019 - 2024)

  • April 2019
  • 125 pages
  • ID: 5778436
  • Format: PDF
  • By Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

Market Overview
Allergy plays a significant role in patients with atopic dermatitis. The disease mostly flares up when the patient is around things that cause allergic reactions. It is particularly common in infants as well as children and is estimated to account for about 10-20% for those having eczema, as mentioned under the American College of Allergy, Asthma & Immunology. Food allergy has been essentially highly debatable for decades in atopic dermatitis, with some common food, including milk, egg, and soy. There is a lot of literature which provides evidence that common food exacerbate atopic dermatitis. The malfunction in the immune system of the human body due to asthma is also among the major causes for atopic dermatitis. In addition, skin irritants also occur because of certain soaps, detergents, perfumes etc. Thus, the allergic reactions particularly due to food is one major factor increasing the burden of atopic dermatitis and driving this market. Other factors driving this market is the rich pipeline portfolio with products in advanced stages of clinical development, increasing government funds to support research for this disease, and rising campaigns to raise eczema awareness.

Scope of the Report
Atopic dermatitis, also known as atopic eczema, often related as just a ‘skin condition’ is a misconception, which people think can be dealt with on their own. However, it impacts the patient’s life physically and emotionally. Its market mostly consists of topical treatment, steroids, and calcineurin inhibitors, primarily driven by the increasing burden of allergic reactions, including food allergy, rising campaigns for awareness, as well as high R&D in this field. The regional analysis demonstrated North America to be a dominant market for atopic dermatitis, primarily owing to higher treatment awareness among the target population, early adoption of novel medications, and better reimbursement policies.

Key Market Trends
Corticosteroids Segment Dominated the Overall market by drug class

Corticosteroids are referred to as cortisone-like medicines that are used as pain relief medication for inflammation in the body. These drugs are known to have effects, such as reduced itching, swelling, allergic reactions, and redness. In addition, these drugs are use as the first line treatment for different diseases, such as skin problems, severe allergies, arthritis, and asthma. Around 30 corticosteriod compunds have been licensed for atopic dermatitis treatment of which Hydrocortisone is considered to be the first. The rising innovations have led to the advent of counterfeit medicines and alternative drugs such as immuno-modulators pimecrolimus, and tacrolimus. However, these alternatives have pitfalls, such as selective effectiveness and high cost. Hence, topical corticosteroids play a vital role in the atopic dermatitis treatment.

North America captured the largest market share and is expected to retain its dominance

North America is expected to provide high business for the atopic dermatitis market, over the forecast period, 2019-2024. The factors, such as high treatment awareness among the patient population across the United States and Canada, healthcare infrastructure, early adoption of novel medications, better reimbursement policies, and increasing business partnerships of pharmaceutical companies with contract research organizations in the emerging markets help the lucrative nature of this market in North America. Though both countries deal with heavy healthcare expenditure, there are an increasing number of campaigns organized each year by certain foundations, such as the PAN Foundation, National Eczema Associations, and pharmaceutical companies along with grants.

Competitive Landscape
The presence of major market players, such as Pfizer, F Hoffmann-La Roche, Allergan, Novartis, and Bayer AG, is increasing the overall competitive rivalry of the market. Large organizations rely heavily on advertising expenses and branding strategies. They are also collaborating with successful personalities, initiatives, or programs at the national levels, which promote their product, and are, thus, recognized earlier than other brands in the market.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($4250)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Pruritus - Pipeline Review, H2 2019

Pruritus - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Pruritus - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Pruritus - Pipeline Review, H2 2019, provides an overview of the Pruritus (Dermatology) pipeline ...

Cryptococcosis - Pipeline Review, H2 2019

Cryptococcosis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Cryptococcosis - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Cryptococcosis - Pipeline Review, H2 2019, provides an overview of the Cryptococcosis (Infectious Disease) ...

Ocular Hypertension - Pipeline Review, H2 2019

Ocular Hypertension - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Ocular Hypertension - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2019, provides an overview of the Ocula ...

Warts - Pipeline Review, H2 2019 $ 2000 September 2019


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on